The healthcare “MIDDLEMEN” always try to maximize their profits – guess who pays ?

Express Scripts, Others Face ERISA Suit Over EpiPen Costs

Law360, New York (August 29, 2017, 4:09 PM EDT) — Pharmacy benefit managers Express Scripts Inc., OptumRx Inc. and Prime Therapeutics LLC have agreed to give Mylan Pharmaceuticals Inc.’s EpiPen favorable placement on drug formularies in exchange for kickbacks, employees under Employee Retirement Income Security Act benefit plans claimed in a proposed class action filed Tuesday in Kansas federal court.

Drugmakers such as Mylan inflate the price of EpiPens and other products to be able to rebate a portion of their profit back to pharmacy benefit managers in exchange for preferential formulary placement, the proposed class…

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading